Guides for clinics adding a regenerative medicine service line
Each guide answers one question an independent clinic owner asks before adding a regenerative service line, and links the regulation, FDA guidance or state rule it relies on. The guides are educational only and are not medical or legal advice.
All guides
- What is the difference between a 361 HCT/P and a 351 biologic, and why does it matter to a clinic owner?
How a 361 HCT/P differs from a 351 biological product under the Public Health Service Act, side by side, and what a clinic owner should ask a supplier.
Regulation and compliance · Updated - How can a chiropractic clinic legally add a regenerative medicine service line?
It depends on the state. What Texas, Florida and New Mexico's own texts say about chiropractic scope, the federal product rules, and what to ask your board.
Launching a service line · Updated - What are the FDA 361 HCT/P criteria and what do they mean for clinics?
The four criteria in 21 CFR 1271.10(a) that decide whether an HCT/P is regulated solely under section 361, and what a clinic should ask its suppliers.
Regulation and compliance · Updated - How can a clinic market regenerative services to patients without making claims it cannot support?
What a clinic should leave out of regenerative marketing, what it can describe instead, and what FDA and FTC rules say about claims, endorsements and consent.
Patient marketing · Updated - What should an independent clinic have in place before launching a regenerative service line?
A checklist for independent clinics: confirm scope under state law, document each product's status, then protocols, compliant wording, consent and follow up.
Launching a service line · Updated